[
  {
    "ts": null,
    "headline": "Boston Scientific Corp. stock underperforms Thursday when compared to competitors despite daily gains",
    "summary": "Boston Scientific Corp. stock underperforms Thursday when compared to competitors despite daily gains",
    "url": "https://finnhub.io/api/news?id=fb722cf801c543b8f946bd6a9c17403366dde70ff94189f1420d907391b1710e",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1735836000,
      "headline": "Boston Scientific Corp. stock underperforms Thursday when compared to competitors despite daily gains",
      "id": 132324594,
      "image": "",
      "related": "BSX",
      "source": "MarketWatch",
      "summary": "Boston Scientific Corp. stock underperforms Thursday when compared to competitors despite daily gains",
      "url": "https://finnhub.io/api/news?id=fb722cf801c543b8f946bd6a9c17403366dde70ff94189f1420d907391b1710e"
    }
  },
  {
    "ts": null,
    "headline": "McKesson Stock Declines Post Divestiture of Canada-Based Businesses",
    "summary": "MCK aims to focus on capital deployment and prioritize investments to strengthen its strategic oncology and biopharma growth platforms.",
    "url": "https://finnhub.io/api/news?id=53116e6f35f0ffedb0757ebe52e0623e6b6518e2f057a05fd3e14a6bfba42338",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1735833840,
      "headline": "McKesson Stock Declines Post Divestiture of Canada-Based Businesses",
      "id": 132242128,
      "image": "https://media.zenfs.com/en/zacks.com/c8704ffaba0234da981fa842a48f77b5",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "MCK aims to focus on capital deployment and prioritize investments to strengthen its strategic oncology and biopharma growth platforms.",
      "url": "https://finnhub.io/api/news?id=53116e6f35f0ffedb0757ebe52e0623e6b6518e2f057a05fd3e14a6bfba42338"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific Announces Participation in the J.P. Morgan Healthcare Conference and Conference Call Discussing Fourth Quarter 2024 Results",
    "summary": "Boston Scientific Corporation (NYSE: BSX) will participate in the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025, in San Francisco. Mike Mahoney, chairman and chief executive officer, will present at approximately 5:15 p.m. PT / 8:15 p.m. ET. Mahoney will be joined by Dan Brennan, executive vice president and chief financial officer, and Kenneth Stein, M.D., senior vice president and chief medical officer, in a question-and-answer session with the host analyst.",
    "url": "https://finnhub.io/api/news?id=f7d641b000fd568d88d18e3457246a59497cecb5fac5eeedf310ee20a8674a8a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1735822800,
      "headline": "Boston Scientific Announces Participation in the J.P. Morgan Healthcare Conference and Conference Call Discussing Fourth Quarter 2024 Results",
      "id": 132239013,
      "image": "https://media.zenfs.com/en/prnewswire.com/02e6d5e710acee0e3d3509b5490e4888",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Boston Scientific Corporation (NYSE: BSX) will participate in the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025, in San Francisco. Mike Mahoney, chairman and chief executive officer, will present at approximately 5:15 p.m. PT / 8:15 p.m. ET. Mahoney will be joined by Dan Brennan, executive vice president and chief financial officer, and Kenneth Stein, M.D., senior vice president and chief medical officer, in a question-and-answer session with the host analyst.",
      "url": "https://finnhub.io/api/news?id=f7d641b000fd568d88d18e3457246a59497cecb5fac5eeedf310ee20a8674a8a"
    }
  },
  {
    "ts": null,
    "headline": "Should You Retain Charles River Stock in Your Portfolio Now?",
    "summary": "CRL's solid prospects in the RMS segment and solid financial stability create a favorable outlook for investors.",
    "url": "https://finnhub.io/api/news?id=0da4dd90c70ed4285ea8dcfd9b50672d9a411bef91cb834b2945cf26e5eb2e2d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1735820220,
      "headline": "Should You Retain Charles River Stock in Your Portfolio Now?",
      "id": 132238703,
      "image": "https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "CRL's solid prospects in the RMS segment and solid financial stability create a favorable outlook for investors.",
      "url": "https://finnhub.io/api/news?id=0da4dd90c70ed4285ea8dcfd9b50672d9a411bef91cb834b2945cf26e5eb2e2d"
    }
  },
  {
    "ts": null,
    "headline": "Is Boston Scientific Stock a Smart Pick for Your Portfolio Right Now?",
    "summary": "Investors continue to be optimistic about BSX, courtesy of its international expansion efforts and WATCHMAN's performance.",
    "url": "https://finnhub.io/api/news?id=96e6a0a42ca439a8dd5c447dfedb71617d5f2559341139da6aaff88874d8d89f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1735816980,
      "headline": "Is Boston Scientific Stock a Smart Pick for Your Portfolio Right Now?",
      "id": 132239015,
      "image": "https://media.zenfs.com/en/zacks.com/41b7bdd28f63138df08f17b665d3589a",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Investors continue to be optimistic about BSX, courtesy of its international expansion efforts and WATCHMAN's performance.",
      "url": "https://finnhub.io/api/news?id=96e6a0a42ca439a8dd5c447dfedb71617d5f2559341139da6aaff88874d8d89f"
    }
  },
  {
    "ts": null,
    "headline": "Top 10 medtech deals of 2024",
    "summary": "Multibillion-dollar buyouts returned last year, led by Johnson & Johnson’s $13.1 billion acquisition of Shockwave Medical.",
    "url": "https://finnhub.io/api/news?id=41940661de87b767c3f4e426f1a4976c2682fa6583d94e825dadf54b32c0df70",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1735814520,
      "headline": "Top 10 medtech deals of 2024",
      "id": 132244707,
      "image": "https://imgproxy.divecdn.com/bKIy4ceTn7PxeXEpUtVNe42wMaiktUyfrpu2Gq0gziA/g:ce/rs:fit:770:435/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xNzQxMzEzMzE2LmpwZw==.webp",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Multibillion-dollar buyouts returned last year, led by Johnson & Johnson’s $13.1 billion acquisition of Shockwave Medical.",
      "url": "https://finnhub.io/api/news?id=41940661de87b767c3f4e426f1a4976c2682fa6583d94e825dadf54b32c0df70"
    }
  }
]